California's Randy Mills: Flood of Demand for Stem Cell Therapies Requires New Development Pathways
The president of the $3 billion California stem cell agency today told federal regulators that patient demand is "very real" for stem cell therapies and called for "alternative" pathways for development.
Randy Mills at FDA hearingRandy Mills said patients are "really suffering and their needs are not being met." He said the demand is like a flood of wate…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.